The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections

International Journal of Antimicrobial Agents

Volumn 34, Issue 5, 2009, Pages 407-413

  Schito, Gian Carlo ^a   Naber, Kurt G ^b   Botto, Henry ^c   Palou, Juan ^d   Mazzei, Teresita ^e   Gualco, Laura ^a   Marchese, Anna ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c FOCH HOSPITAL   (France)

^d FUNDACIÓ PUIGVERT   (Spain)

^e UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Amoxicillin clavulanic acid; Ciprofloxacin; Cystitis; Escherichia coli; Fosfomycin

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; MECILLINAM; NALIDIXIC ACID; NITROFURANTOIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BRAZIL; CITROBACTER; CYSTITIS; ENTEROBACTER; ENZYME ANALYSIS; ESCHERICHIA COLI; EUROPE; HAFNIA ALVEI; HUMAN; IN VITRO STUDY; ITALY; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; MULTIDRUG RESISTANCE; NONHUMAN; PANTOEA; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; RUSSIAN FEDERATION; SALMONELLA; SERRATIA; SPAIN; STAPHYLOCOCCUS SAPROPHYTICUS; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIA; BRAZIL; DRUG RESISTANCE, BACTERIAL; EUROPE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; URINARY TRACT INFECTIONS;

EID: 69949132847     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.04.012     Document Type: Article

References (26)

1. Grabe M, Bishop MC, Bjerklund-Johansen TE, Botto H, Çek M, Lobel B, et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Arnhem, The Netherlands: EAU; 2006. http://www.uroweb.org [accessed 10 December 2008].
2. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 51 (2003) 69-76
3. Hooton T.M., Besser R., Foxman B., Fritsche T.R., and Nicolle L.E. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 39 (2004) 75-80
4. Raz R., Chazan B., Kennes Y., Colodner R., Rottensterich E., Dan M., et al. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 34 (2002) 1165-1169
5. Naber K.G., Schito G., Botto H., Palou J., and Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol 54 (2008) 1164-1178
6. Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., and Stamm W.E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15 Suppl. 1 (1992) S216-S227
7. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 7th ed. Approved standard M7-A7. Wayne, PA: CLSI; 2006.
8. Mugnaioli C., Luzzaro F., De Luca F., Brigante G., Perilli M., Amicosante G., et al. CTX-M-type extended-spectrum β-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 50 (2006) 2700-2706
9. Naber K.G., Bergman B., Bishop M.C., Bjerklund-Johansen T.E., Botto H., Lobel B., et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 40 (2001) 576-588
10. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe: The ECO.SENS study. Int J Antimicrob Agents 22 Suppl. 2 (2003) 49-52
11. Raz R., Colodner R., and Kunin C.M. Who are you-Staphylococcus saprophyticus?. Clin Infect Dis 40 (2005) 896-898
12. Fadda G., Nicoletti G., Schito G.C., and Tempera G. Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines. J Chemother 17 (2005) 251-257
13. Stratchounski L.S., and Rafalski V.V. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies UTIAP-1 and UTIAP-2. Int J Antimicrob Agents 28 Suppl. 1 (2006) S4-9
14. Andrade S.S., Sader H.S., Jones R.N., Pereira A.S., Pignatari A.C., and Gales A.C. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?. Mem Inst Oswaldo Cruz 101 (2006) 741-748
15. Karlowsky J.A., Hoban D.J., Decorby M.R., Laing N.M., and Zhanel G.G. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob Agents Chemother 50 (2006) 2251-2254
16. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48 (2004) 1-14
17. Colodner R., Rock W., Chazan B., Keller N., Guy N., Sakran W., et al. Risk factors for the development of extended-spectrum β-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23 (2004) 163-167
18. Goossens H., Ferech M., Vander Stichele R., Elseviers M., and ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 (2005) 579-587
19. Kahlmeter G., and Menday P. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO·SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother 52 (2003) 128-131
20. Ho P.L., Wong R.C., Yip K.S., Loke S.L., Leung M.S., Mak G.C., et al. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn Microbiol Infect Dis 59 (2007) 439-445
21. Ungheri D., Albini E., and Belluco G. In vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol. J Chemother 14 (2002) 237-240
22. Smith S.P., Manges A.R., and Riley L.W. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition. Clin Infect Dis 46 (2008) 689-695
23. Manges A.R., Johnson J.R., Foxman B., O'Bryan T.T., Fullerton K.E., and Riley L.W. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 345 (2001) 1007-1013
24. Prats G., Navarro F., Mirelis B., Dalmau D., Margall N., Coll P., et al. Escherichia coli serotype O15:K52:H1 as a uropathogenic clone. J Clin Microbiol 38 (2000) 201-209
25. Nicolas-Chanoine M.H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M.P., Caniça M.M., et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61 (2008) 273-281
26. Cagnacci S., Gualco L., Debbia E., Schito G.C., and Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 46 (2008) 2605-2612